Drug Industry Antitrust Act

Hearings Before the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, Eighty-seventh Congress, First [-second] Session, Pursuant to S. Res. 52 on S. 1552, a Bill to Amend and Supplement the Antitrust Laws, with Respect to the Manufacture and Distribution of Drugs, and for Other Purposes

• Author(s): United States. Congress. Senate. Committee on the Judiciary,
• Publisher: U.S. Government Printing Office
• Pages: 1244
• Language: en